Lenalidomide Maintenance for High Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation

Allogeneic hematopoietic cell transplantation (alloHCT) with reduced intensity conditioning is an appealing option for patients with high risk multiple myeloma (MM). However, progression after alloHCT remains a challenge. Maintenance therapy after alloHCT may offer additional disease control and all...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Alsina, Melissa, Becker, Pamela S., Zhong, Xiaobo, Adams, Alexia, Hari, Parameswaran, Rowley, Scott, Stadtmauer, Edward A., Vesole, David H., Logan, Brent, Weisdorf, Daniel, Qazilbash, Muzaffar, Popplewell, Leslie L., McClune, Brian, Bensinger, William, Riches, Marcie, Giralt, Sergio A., Pasquini, Marcelo C.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036168/
https://ncbi.nlm.nih.gov/pubmed/24769014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.04.014
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items